
GENERAL DISCLOSURES
Our stakeholders are our priority
We operate in a dynamic international context, where the involvement of stakeholders - based on the values of honesty, transparency, and open dialog - is essential for pursuing our goal of generating shared economic and social value.
For this reason, adopting a perspective of mutual learning and sharing, we constantly promote activities of listening, interaction, and dialog, in order to develop the most sustainable growth strategies.
In 2022, we updated our stakeholder categories, defining a Stakeholder Engagement Plan that will allow us to engage, on a rotation basis, the majority of our stakeholders. Using different interactive modalities and based on a structured process.
Who are our stakeholders
We are in regular contact with our key stakeholders (people suffering from hearing loss & caregivers, workforce, franchisees & agents, industry & consumers associations, shareholders, providers of capital, & financial community) as well as with hearing aid manufacturers, trade unions, the academia & medical class, indirect suppliers & other value chain actors, regulatory authorities & health care systems, local & global communities, and the media.
PEOPLE WITH HEARING LOSS & CAREGIVERS
WORKFORCE
FRANCHISEES & AGENTS
SHAREHOLDERS, PROVIDERS OF CAPITAL, FIN. COMMUNITY
INDUSTRY & CONSUMERS ASSOCIATIONS
Our materiality analysis
The materiality analysis represents the pivotal process underlying the drafting of our Sustainability Statement, and aims to identify, among the various economic, environmental and social topics, those matters which, at the same time, are the most important for both our Organization and our stakeholders.
Already back in 2021, we introduced the concept of “double materiality”, valuing at the same time both Amplifon’s contribution to individual economic, environmental, and social topics significant to the market, environment and people (ESG materiality), as well as to what extent these global topics and macro-trends can impact the Company’s financial performance and its ability to create value (financial materiality).
This specific dual perspective was utilized also in 2024, employing a dynamic approach, looking at current trends and drivers of our sector and of the ESG world. We are conscious that today’s non-material topics could gain relevance in the near future
what is relevant for us
Find out how we approach our material topics.
ENVIRONMENTAL INFORMATION
We know the importance of reducing the environmental impact of our operations and adopting sustainable practices throughout the value chain. Therefore, we are committed to reducing emissions with innovative, low-impact solutions.
Social Information
Our people are the most important asset for our business. It is crucial to attract, develop and retain key resources and to ensure equal opportunities and well-being for our people.
governance information
We conduct our activities following the highest ethical and moral standards, ensuring maximum transparency to our stakeholders. Proper business management is based on the principles of the Code of Ethics, which ensures responsible behaviour.
Constant monitoring of the regulatory framework
We operate in a medical sector, where regulations vary from country to country. We constantly monitor the regulatory framework with the aim of reducing the impact of any unfavorable changes and maximizing the benefits of favorable ones.
Through the establishment of the Regulatory Affairs function, we have implemented a series of measures not only to monitor the regulatory framework in place and any potential change in all the countries in which we operate, but also to ensure a timely reaction to any potential changes in regulation, besides being able to engage in dialogue with institutions and actively take part in debates and conventions to make the voice of the sector heard.
three main regulatory areas
regulation on medical devices
regulation on hearing care professionals
reimbursement conditions
Reimbursement conditions also differ according to different national health systems. There are national health systems that offer hearing aids free of charge to everyone, like in the United Kingdom, and others, like in France and Italy, that partially or fully reimburse the cost of the hearing aid to people with a certain level of hearing impairment. Lastly, some healthcare systems do not offer any reimbursement, like in Spain and in the US.
In all countries, we promote efficient reimbursement systems and we participate in the debate with healthcare companies and regulators, to seek the right balance between free access to hearing care on the one hand, and on the other hand the maintenance of the economic sustainability of health systems.